Advertisement
Screener

Acumen Pharmaceuticals, Inc. (ABOS) Other

Acumen Pharmaceuticals, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market.
  • 2025-03-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market.
  • 2024-03-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market.
  • 2023-03-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market.
FiledFormItemAs filed
2026-03-2610-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market
2025-03-2710-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market
2024-03-2610-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market
2023-03-2710-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · ABOS · The Nasdaq Global Select Market
2021-08-1610-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48